Cargando…
Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells
BACKGROUND: Endothelial dysfunction, characterized by diminished endothelial progenitor cell (EPC) function and flow-mediated vasodilation (FMD), is a clinically significant feature of heart failure (HF). Mesenchymal stem cells (MSCs), which have pro-angiogenic properties, have the potential to rest...
Autores principales: | Premer, Courtney, Blum, Arnon, Bellio, Michael A., Schulman, Ivonne Hernandez, Hurwitz, Barry E., Parker, Meela, Dermarkarian, Christopher R., DiFede, Darcy L., Balkan, Wayne, Khan, Aisha, Hare, Joshua M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485912/ https://www.ncbi.nlm.nih.gov/pubmed/26137590 http://dx.doi.org/10.1016/j.ebiom.2015.03.020 |
Ejemplares similares
-
Rethinking Endothelial Dysfunction as a Crucial Target in Fighting Heart Failure
por: Premer, Courtney, et al.
Publicado: (2019) -
Mesenchymal Stem Cell Secretion of SDF-1α Modulates Endothelial Function in Dilated Cardiomyopathy
por: Premer, Courtney, et al.
Publicado: (2019) -
Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy
por: Rieger, Angela C., et al.
Publicado: (2019) -
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty
por: Golpanian, Samuel, et al.
Publicado: (2016) -
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty
por: Golpanian, Samuel, et al.
Publicado: (2017)